Nutraceutical Excipients Market: A Research Analysis of Emerging Technologies and Opportunities in 2028


According to a report by TechSci Research titled “Global Nutraceutical Excipients Market – Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028″, the Global Nutraceutical Excipients Market reached a value of $4.32 billion in 2022 and is projected to experience a compound annual growth rate (CAGR) of 7.2% during the forecast period of 2024 to 2028. Nutraceutical excipients, which are inactive components combined with Active Pharmaceutical Ingredients (API) to enhance the effectiveness of solutions containing active substances, are utilized in standardized and pharmaceutical-grade supplements. These excipients play a crucial role in maintaining the stability of compounds that can be affected by factors such as heat, light, oxygen, alkaline pH, and high humidity.

Moreover, these excipients contribute to the stability of compounds that are sensitive to various factors like heat, light, oxygen, alkaline pH, and high humidity. They are employed in the production of a range of supplements, including tablets, capsules, powders, and liquid syrups, providing functions such as fillers, diluents, disintegrants, binders, coating agents, flavoring agents, colorants, sweeteners, and lubricants.

The increasing adoption of prebiotics and probiotics, coupled with the rising prevalence of lifestyle diseases globally, is propelling the demand for nutraceutical excipients. The growing elderly population and the uptick in cases of conditions like osteoporosis and cardiovascular diseases are driving the uptake of nutritional foods and dietary supplements. The use of dry nutraceutical excipients is also on the rise, aiming to address prevalent issues such as osteoarthritis, diabetes, thyroid disease, and obesity.


Browse over 26 market data Figures spread through 91 Pages and an in-depth TOC on “Global Nutraceutical Excipients Market.” –


Nutraceutical products not only provide nutrition but can also serve as medicinal interventions. Substances that confer physiological benefits or protection against chronic diseases fall under the category of nutraceutical products. These products promote well-being, slow down aging, prevent chronic diseases, extend life expectancy, and support bodily functions and structures. Despite sharing potential benefits with pharmaceuticals, only the latter receive government approval for disease prevention or treatment. Nevertheless, nutraceuticals have garnered significant attention due to their potential nutritional, safety, and therapeutic effects.

For instance, probiotics, which contain beneficial bacteria and yeast, offer various advantages such as improved digestion, gut health, immunity, and nutrient absorption. DFE Pharma, a key player in pharmaceutical excipient solutions, introduced “BioHale,” a product line catering to the global demand from biopharmaceutical companies, in April 2021.

Challenges to the market’s growth prospects include diminishing returns on research and development (R&D) investments and the high costs associated with clinical trials and registration. High R&D investments often yield disproportionate returns in terms of productivity. Additionally, the introduction of new nutraceutical products and excipients incurs high costs and associated risks. Clinical trials to demonstrate excipient effectiveness are expensive, serving as a barrier to novel excipient development.

Stabilizing the physicochemical properties of nutraceuticals, driven by their inherent instability, and the demand for versatile excipients are expected to fuel market growth. Drug-carrier associations can enhance the physicochemical properties of drugs, optimizing pharmacokinetics and cellular penetration, addressing solubility, degradation, clearance, toxicity, and barrier-crossing challenges.

The Global Nutraceutical Excipients Market is categorized by form, functionality, product, distribution channel, regional distribution, and company. During the forecast period, the probiotics segment is predicted to be the largest in the nutraceutical excipients market. The appeal of probiotic-fortified foods, the versatility of probiotics, and increasing consumer awareness of balanced diets are driving global demand. Prebiotics and probiotics are gaining traction as dietary supplements due to the growing prevalence of lifestyle disorders. This growth is particularly pronounced in the context of pre- and probiotic consumption.

The North American segment is poised to grow during the forecast period, holding the largest market share and a dominant position in the nutraceutical excipients market. This growth is attributed to factors like busy consumer lifestyles, heightened awareness of health benefits, and advancements allowing innovative excipient use.

The Asia Pacific region, including China, India, and Japan, is projected to experience the highest growth in the nutraceutical excipients market. Rising income, a growing middle-class population, increased health consciousness, and demand for nutritional products contribute to this trend. Market players are capitalizing on population growth, driving demand for nutraceutical excipients.

Major companies operating in Global Nutraceutical Excipients Market are:

  • ABF Ingredients
  • Cargill, Inc.
  • Dow, Inc.
  • DuPont de Nemours, Inc.
  • EGGLE Wasserburg Verwaltungs GmbH
  • Hilmar Ingredients
  • IMCD Group BV
  • Ingredion, Inc.
  • Innophos Holdings, Inc.
  • Jrs Pharma GmbH Co. KG

Download Free Sample Report


Customers can also request for 10% free customization on this report.

“The increasing focus of consumers on nutrition and dietary supplements has spurred nutraceutical excipient producers to prioritize innovative launches and cater to the rising demand in the food and beverage industry. As an example, Innophos announced the introduction of multifunctional excipients in nutraceuticals and dietary supplements in February 2021. A-TAB® MD and NUTRA-TAB® CPMEs have been specifically developed to aid manufacturers by utilizing co-processed multifunctional excipients (CPMEs) to streamline labeling and enhance compressibility, thereby reducing tablet size and improving manufacturing efficiency. The growing prevalence of lifestyle diseases like obesity and diabetes has led to increased consumption of prebiotics and probiotics in the United States, subsequently creating opportunities for the application of nutraceutical excipients in the country’s food sector. According to the Centers for Disease Control and Prevention (CDC), obesity rates in the United States currently stand at 42.4% and are projected to rise further due to the fast-paced lifestyle prevalent in the country.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Global Nutraceutical Excipients Market By Form (Liquid, Dry), By Functionality (Binders, Disintegrants, Flavoring Agents, Coating Agents, Fillers & Diluents, Lubricants, Other Functionalities), By End-Product (Protein & Amino Acids, Vitamins, Probiotics, Omega-3 fatty acids, Minerals, Other End Products), By Distribution Channel (Direct Tender, Retail Sales and Others), By Region, By Competition Forecast & Opportunities, 2018-2028F, has evaluated the future growth potential of Global Nutraceutical Excipients Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Nutraceutical Excipients Market.

Download Free Sample Report –

About TechSci Research:

TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.


Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656